Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,073,684
  • Shares Outstanding, K 131,225
  • Annual Sales, $ 9,437 M
  • Annual Income, $ 1,431 M
  • 60-Month Beta 1.04
  • Price/Sales 1.80
  • Price/Cash Flow 9.22
  • Price/Book 2.52
Trade DGX with:

Options Overview

Details
  • Implied Volatility 24.88%
  • Historical Volatility 14.06%
  • IV Percentile 1%
  • IV Rank 2.54%
  • IV High 47.17% on 04/21/20
  • IV Low 24.30% on 04/12/21
  • Put/Call Vol Ratio 0.34
  • Today's Volume 484
  • Volume Avg (30-Day) 799
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 14,557
  • Open Int (30-Day) 8,797

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 3.78
  • Number of Estimates 8
  • High Estimate 4.09
  • Low Estimate 3.62
  • Prior Year 0.94
  • Growth Rate Est. (year over year) +302.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.03 +6.62%
on 03/18/21
132.24 -1.61%
on 04/05/21
+7.43 (+6.06%)
since 03/16/21
3-Month
113.36 +14.78%
on 02/23/21
134.71 -3.41%
on 02/01/21
+5.72 (+4.60%)
since 01/15/21
52-Week
92.55 +40.58%
on 04/21/20
134.71 -3.41%
on 02/01/21
+39.36 (+43.37%)
since 04/16/20

Most Recent Stories

More News
Airspace Unveils Bold New Brand, Launches Revamped Website as It Expands Industries Served and Time-Critical Logistics Services

Airspace, a leading global delivery network for time-critical logistics, introduced bold new branding and launched a contemporary new website today at www.airspace.com. This news comes on the heels of...

DGX : 130.11 (+0.74%)
Quest Diagnostics and Blueprint Genetics to Present New Insights from Genetic Testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting

and , /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced today that they will present results of 10 studies...

DGX : 130.11 (+0.74%)
Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22

, /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on ,...

DGX : 130.11 (+0.74%)
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

Style Box ETF report for DEF

DEF : 63.81 (+0.55%)
DGX : 130.11 (+0.74%)
EBAY : 64.93 (+0.89%)
AMGN : 255.71 (+0.23%)
QQQ : 342.01 (+0.12%)
VUG : 276.47 (+0.03%)
Quest Diagnostics (DGX) Rides on Test Sales Amid Volume Woe

Quest Diagnostics (DGX) enters into an agreement with the CDC to provide genomic sequencing to identify new mutations in and patterns of transmission of SARS-CoV-2.

DGX : 130.11 (+0.74%)
CFMS : 0.8469 (+2.16%)
CMD : 86.74 (+0.51%)
ASXC : 1.7500 (-6.91%)
U.S. Genetic Testing Market Size 2021 | To Exhibit 13.0% CAGR and is expected to gain momentum by reaching USD 10.29 billion by 2027

The U.S. genetic testing market size is expected to gain momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of 13.0% between 2020 and 2027.

FLGT : 90.50 (+0.09%)
MYGN : 27.31 (-5.04%)
DGX : 130.11 (+0.74%)
Quest Diagnostics (DGX) Divests Minority Share of Q2 Solutions

Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.

XRAY : 65.42 (+0.91%)
DGX : 130.11 (+0.74%)
MCK : 193.18 (+0.95%)
IVC : 8.79 (-1.12%)
IQVIA (IQV) Buys Remaining Q2 Solutions Stake, Ups EPS View

The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.

CRAI : 76.44 (+3.00%)
OMC : 79.65 (+0.26%)
DGX : 130.11 (+0.74%)
IT : 191.98 (+0.72%)
IQV : 215.56 (+0.67%)
Global Healthcare Revenue Cycle Management Software Market (2021 to 2025) - Featuring 3M, Change Healthcare and Quest Diagnostics Among Others - ResearchAndMarkets.com

The "Global Healthcare Revenue Cycle Management (RCM) Software Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

DGX : 130.11 (+0.74%)
Infectious Disease Point of Care Diagnostics Market Size 2021 | To Rise at 17.4% CAGR and Hit USD 3371.1 Million till 2027

The global "infectious disease point of care (PoC) diagnostics" market size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will...

ABT : 124.35 (+0.33%)
CAH : 61.31 (+0.72%)
CPHD : 52.95 (unch)
DGX : 130.11 (+0.74%)
TRIB : 3.60 (-7.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

3rd Resistance Point 132.67
2nd Resistance Point 131.62
1st Resistance Point 130.87
Last Price 130.11
1st Support Level 129.06
2nd Support Level 128.01
3rd Support Level 127.25

See More

52-Week High 134.71
Last Price 130.11
Fibonacci 61.8% 118.60
Fibonacci 50% 113.63
Fibonacci 38.2% 108.66
52-Week Low 92.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar